17 research outputs found
Time since disease onset in chronic illness observed in France and generated by the model.
<p>Time since disease onset in chronic illness observed in France and generated by the model.</p
Probabilistic sensitivity analysis frequency and cumulative frequency of incremental cost-effectiveness ratio (ICER: incremental cost-effectiveness ratio; LYG: life-year gained).
<p>Probabilistic sensitivity analysis frequency and cumulative frequency of incremental cost-effectiveness ratio (ICER: incremental cost-effectiveness ratio; LYG: life-year gained).</p
Schematic diagram of Markov model estimating effectiveness of smoking cessation strategies.
<p>Schematic diagram of Markov model estimating effectiveness of smoking cessation strategies.</p
Probabilistic sensitivity analysis frequency and cumulative frequency of cost of cessation treatment.
<p>Probabilistic sensitivity analysis frequency and cumulative frequency of cost of cessation treatment.</p
ICER per LYG stratified by age and gender in base case.
<p>ICER per LYG stratified by age and gender in base case.</p
Life expectancy in France at age 20 in the general population and as estimated by the model by smoking behavior.
<p>Life expectancy in France at age 20 in the general population and as estimated by the model by smoking behavior.</p
Additional file 1: of Geographic variations in involuntary care and associations with the supply of health and social care: results from a nationwide study
Description of the different databases used in the study. Table including the name, main content and data compilation method for each database included in the study. (DOCX 17 kb
Baseline patient characteristics.
<p>Values are mean values (SD) or number of patients (%).</p>1<p>Eular Guideline: 1st rheumatologist visit after RA onset <45 days; ESR = Erythrocyte sedimentation rate, CRP = C-Reactive Protein, DAS-28 = Disease Activity Score 28, HAQ = Health Assessment Questionnaire, ACR = American College of Rheumatology, VAS = Visual analogue scale, EULAR = European League Against Rheumatism, DMARD = Disease-modifying antirheumatic drug, ACPA = anti-citrullinated protein antibody.</p